These trials completed more than 12 months ago and should have reported results.

These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.

These trials have problematic data on the registry. Details why »

Status Trial ID Title Completion date Category
Ongoing 2005-003411-75 Estudio sobre la utilización de levetiracetam en monoterapia en pacientes HIV-positivos con epilepsia not-yet-due
Ongoing 2006-006842-33 Estudio Piloto Comparativo de Eficacia, Tolerancia y Seguridad de Moxifloxacino VO frente a Levofloxacino en Terapia Secuencial en Adultos Inmunocompetentes con Neumonía Adquirida en la Comunidad. not-yet-due
Completed, but no date 2011-000619-16 Identification of the effect of allopurinol treatment on platelets from diabetic patients with stable coronary ischemic disease and aspirin resistance. XUE Study. Estudio cruzado para valorar el efec... bad-data
Exempt 2011-001393-26 Phase II clinical trial to evaluate the feasibility and safety of human adipose derived mesenchymal stem cells on chronic ischaemic stroke. Ensayo Clínico en fase IIa para conocer la factibilidad y... not-yet-due
Completed, but no date, and reported results 2014-004020-21 Reintroduction of platinum-based therapy after treatment with trabectedin in patients with relapsed ovarian cancer resistant to platinum Reintroducción de tratamiento basado en platino después del ... bad-data
Reported results 2015-001863-38 The impact of proton-pump inhibitors (antacids) on threshold dose distributions Impacto de los inhibidores de la bomba de protones en la distribución de la dosis umbral en pacientes con alergia a l... 2018-06-29 due-trials
Ongoing 2020-000130-18 Co-THEIA (Combination THerapy with mEthotrexate and adalImumAb for uveitis): Efficacy, safety and cost-effectiveness of methotrexate, adalimumab, or their combination in non infectious non anterior uv... not-yet-due
Ongoing 2020-001366-11 An international randomised trial of additional treatments for COVID-19 in hospitalised patients who are all receiving the local standard of care not-yet-due
Ongoing 2021-004868-95 AMANTADINE AND TRANSCRANIAL MAGNETIC STIMULATION FOR TREATING FATIGUE IN MULTIPLE SCLEROSIS: PHASE III STUDY, CONTROLLED, RANDOMIZED, CROSSED OVER AND DOUBLE BLIND AMANTADINA Y ESTIMULACIÓN MAGNÉTI... not-yet-due